Informal consultation on the role of therapeutics in COVID 19 prophylaxis and post-exposure prophylaxis

Overview

Currently, there are no licensed vaccines for the prevention of COVID 19. While efforts continue to develop efficacious vaccines, it is pertinent to examine the possible role of therapeutic agents in protecting healthcare workers and the general populace who are at significant risk of contracting the virus, either before they are exposed to the virus or to prevent the development of clinical disease following exposure.

This expert consultation convened clinical care partners and experts in the field of randomized controlled trials (RCTs), biostatistics, regulatory affairs, preclinical studies, and pharmacology to evaluate current progress in the area of COVID 19 chemoprophylaxis.